Catalysts for Alembic Pharmaceuticals Inc
165 tracked
Dec 19, 2017
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
May 12, 2017
approval
FENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approval
choline fenofibrate
→
Apr 13, 2017
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Apr 13, 2017
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Feb 24, 2017
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Nov 17, 2016
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Oct 12, 2016
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Sep 2, 2016
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 2, 2016
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 2, 2016
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 2, 2016
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Jun 10, 2016
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Apr 4, 2016
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jan 10, 2016
approval
ROPINIROLE HYDROCHLORIDE — FDA approval
ropinirole hydrochloride ER
→
Jan 10, 2016
approval
ROPINIROLE HYDROCHLORIDE — FDA approval
ropinirole hydrochloride ER
→
Oct 26, 2015
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Oct 8, 2015
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 22, 2015
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jul 15, 2015
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jul 15, 2015
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Jul 15, 2015
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 12, 2014
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 12, 2014
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 12, 2014
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 12, 2014
approval
LAMOTRIGINE — FDA approval
Alembic Pharmaceuticals Inc
→
Nov 25, 2014
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→
Sep 25, 2014
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Jun 12, 2014
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Jun 9, 2014
approval
DULOXETINE HYDROCHLORIDE — FDA approval
duloxetine hydrochloride DR
→
Sep 30, 2013
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→